[ad_1]
Pfizer has acquired an all-new manufacturing facility in Sanford, North Carolina, about 40 miles south of the bustling Research Triangle Park.
The pharmaceutical giant has signed a deal to acquire Abzena’s manufacturing plant, which boasts “extensive capacity” for the production of biologic drug substances, the companies said on Tuesday.Pfizer is hiding financial figures for now. The transaction is expected to close in the current quarter.
Construction is underway at a location Abzena chose in April 2021 for “access to qualified labor and other resources.” Abzena said at the time that the new facility would cost him more than $200 million and create about 325 jobs in Sanford.
Pfizer currently has just 100 employees working there, but plans to grow that number to about 300 by 2025, bringing its total workforce in North Carolina to about 4,500, according to a news release. The pharmaceutical giant has poured his $5 billion into US manufacturing capacity over the past five years, including his $1.4 billion in North Carolina.
“Biologics continue to be an integral part of Pfizer’s pipeline and this acquisition will help expand our research, clinical and commercial manufacturing capabilities, accelerate pipeline product development and support Pfizer CentreOne customers. Global Supply Officer Mike McDermott said in a release:
Abzena and Pfizer’s CentreOne contract manufacturing arm will work together on biologics in the future, the companies said.
The Sanford facility was Abzena’s only facility in North Carolina, but the San Diego-based company lists other locations in California, Pennsylvania, and the United Kingdom.
The new facility is near Pfizer’s existing Rocky Mount and Sanford manufacturing sites and near the bustling biotech hub, McDermott said. Just last month, Catalent announced plans to build a new biologics analysis center in Durham, North Carolina. And in November, Fujifilm Irvine Scientific announced that parent company Fujifilm would invest $188 million in Research’s Triangle Park cell culture media manufacturing site.
[ad_2]
Source link